Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
Volume 0.68M
Average 0.41M
SPTX Short-term Debt
Borrowings and the current portion of long-term debt due within one year.
Short-term Debt history
Currency unavailable · from the balance sheet
No Short-term Debt data reported for this period type.
Short-term Debt vs competitors
How SPTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $920K USD | +14.3% | +36.8% | 0.2% | |
LBRXLB Pharmaceuticals Inc Common Stock | Mar 2026 | $730K USD | — | — | 0.2% |
NMRANeumora Therapeutics, Inc. Common Stock | Mar 2026 | $291K USD | — | — | 0.2% |
| Mar 2026 | $0 USD | — | — | 0.0% | |
RAPPRapport Therapeutics, Inc. Common Stock | Mar 2026 | $0 USD | — | — | 0.0% |
CTNMContineum Therapeutics, Inc. Class A Common Stock | Mar 2026 | $0 USD | — | — | 0.0% |
| Mar 2026 | $0 USD | — | — | 0.0% | |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding SPTX) | — | +14.3% | +36.8% | 0.0% | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.